Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.
Emerging issues related to COVID-19 vaccination in patients with cancer / K.S. Saini, D. Martins-Branco, M. Tagliamento, L. Vidal, N. Singh, K. Punie, M.L. Saini, I. Chico, G. Curigliano, E. de Azambuja, M. Lambertini. - In: ONCOLOGY AND THERAPY. - ISSN 2366-1070. - (2021). [Epub ahead of print] [10.1007/s40487-021-00157-1]
Emerging issues related to COVID-19 vaccination in patients with cancer
G. Curigliano
Conceptualization
;
2021
Abstract
Coronavirus disease 2019 (COVID-19) has resulted in millions of deaths globally. The pandemic has had a severe impact on oncology care and research. Patients with underlying cancer are more vulnerable to contracting COVID-19, and also have a more severe clinical course following the infection. The rollout of COVID-19 vaccines in many parts of the world has raised hopes of controlling the pandemic. In this editorial, the authors outline key characteristics of the currently approved COVID-19 vaccines, provide a brief overview of key emerging issues such as vaccine-induced immune thrombotic thrombocytopenia and SARS-CoV-2 variants of concern, and review the available data related to the efficacy and side effects of vaccinating patients with cancer.File | Dimensione | Formato | |
---|---|---|---|
Saini and CURIGLIANO 2021.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
312.96 kB
Formato
Adobe PDF
|
312.96 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.